Adage Capital Partners Gp, L.L.C. Magenta Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.36 - $1.59 $18,000 - $79,500	50,000 Added 6.11%	868,650 $347,000
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $142,002 - $235,542	112,700 Added 15.96%	818,650 $1.15 Million
Q2 2022 Aug 15, 2022	BUY	$0.97 - $3.08 $308,526 - $979,652	318,069 Added 82.0%	705,950 $847,000
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $989,096 - $2.03 Million	387,881 New	387,881 $1.13 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.